Inhibrx Biosciences, Inc. (INBX) stock
INBXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 1/30
$69.06−5.12 (-6.90%)
Close on Nov 18, 2026Market cap $1.02BP/E –Yield –
Inhibrx Biosciences price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Inhibrx Biosciences's price to book ratio was 235.7× on Apr 30, 2026, against 1.3× a year earlier. Over the last 5 years it ranged from 1.0× to 235.7×, with a median of 4.3×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Apr 30, 2026 | 235.7× | +204.6 |
| 2025 | Dec 31, 2025 | 31.1× | +29.8 |
| 2024 | Dec 31, 2024 | 1.2× | −2.2 |
| 2023 | Dec 29, 2023 | 3.5× | −2.7 |
| 2022 | Jul 29, 2022 | 6.2× | −8.5 |
| 2021 | Dec 31, 2021 | 14.7× | +11.3 |
| 2020 | Dec 31, 2020 | 3.4× | – |
See a number that looks wrong?